Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revascularization in Daily Practice). [electronic resource]
Producer: 20160629Description: 1157-1165 p. digitalISSN:- 1876-7605
- Cardiovascular Agents -- administration & dosage
- Coronary Artery Disease -- diagnosis
- Drug-Eluting Stents
- Everolimus -- administration & dosage
- Female
- Humans
- Kaplan-Meier Estimate
- Male
- Metals
- Middle Aged
- Myocardial Infarction -- etiology
- Netherlands
- Paclitaxel -- administration & dosage
- Percutaneous Coronary Intervention -- adverse effects
- Prospective Studies
- Prosthesis Design
- Risk Factors
- Single-Blind Method
- Thrombosis -- etiology
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.